KAT Innovation and its OSTAAT™ medical device recognized for women's health

KAT Innovation has been selected by an independent professional jury to be part of the select group of companies that will be accompanied by FemTech France during the year 2023-24.

KAT Innovation's OSTAAT™ will offer the only solution to tens of millions of women with osteoporosis related to severe chronic kidney disease to reduce the risk of fractures or heal them faster. The medical device will also be the first non-invasive and side-effect-free alternative for the estimated 350 million women worldwide with classical osteoporosis.

Among more than 60 companies applying for FemTech France, eight have been selected to be connected to potential financial partners and to participate in a program that will provide the necessary knowledge to market the medical device successfully in France and Europe.

"The femtech industry is all about innovations that improve women's health. We believe that this medical device project stimulating bone growth in patients suffering from osteoporosis is very promising, says Delphine Moulu, CEO of Femtech France.

FemTech France is an association that support innovative technologies, products and services dedicated to women's health.